Peramivir clearance in continuous renal replacement therapy.
Thomas
Bernadette
B
Hollister
Alan S
AS
Muczynski
Kimberly A
KA
D000146:Acids, Carbocyclic; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D003517:Cyclopentanes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D006146:Guanidines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy; D008297:Male; D008657:Metabolic Clearance Rate; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D006435:Renal Dialysis / Q000379:methods
D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D004791:Enzyme Inhibitors; D006146:Guanidines; D009439:Neuraminidase; C414210:peramivir